Back to search results

BRAVE Program for Violence Risk in Early Psychosis

This study is testing a new behavioral program called BRAVE (Behavioral Response Against Violence Engagement) for young adults aged 18-30 who are experiencing early psychosis (a mental health condition where a person has difficulty telling what is real from what isn't). BRAVE is a type of cognitive behavioral therapy (CBT), which helps people change their thinking and behavior. The goal is to see if BRAVE is practical and acceptable to participants, and if it can help reduce the risk of violent behavior. All participants will first receive their usual care, and then receive the BRAVE program. The study will measure how well participants and therapists work together as a sign of success. This study plans to enroll 30 participants and is currently recruiting.

Study design
This is an interventional study with 30 planned participants. All participants will first receive their usual treatment, then transition to the BRAVE intervention.
What's involved
You would receive weekly BRAVE sessions after a period of usual care. Study assessments will be conducted at regular intervals throughout the study, and you would identify a collateral informant to complete assessments.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, Working Alliance Inventory - Short Revised (WAI-SR), is measured at Baseline and Week 24.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07417904

BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

Recruiting
NAAges 16–30InterventionalPrevention
Howard University
~30 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:BRAVE (Behavioral Response Against Violence Engagement)Treatment As Usual (TAU)

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Working Alliance Inventory - Short Revised (WAI-SR)
Measured over Baseline, Week 24

Conditions

Violence Risk
Early Psychosis

Explore related trials

At increased risk for violencePsychosis

Where it's being run

2 sites across 1 states
District of Columbia2

Who to contact

Stephanie Rolin, MD MPH
[email protected]
(202) 865-6100
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Young adults aged 16-30 years
Diagnosis of early psychosis
Currently receiving outpatient care through an early psychosis clinic
Psychiatrically stable and deemed appropriate for participation by a treating clinician
Able and willing to provide informed consent

Exclusion

Unable to provide informed consent
Not fluent in English
History of antisocial behavior, as assessed at baseline
Immediate risk requiring a higher level of care

What this trial measures

  • Working Alliance Inventory - Short Revised (WAI-SR)Baseline, Week 24

    The WAI-SR is a 12-item self-report measure of therapeutic alliance. Items assess agreement on therapeutic goals and tasks and the participant-therapist bond. Total scores range from 12 to 60, with higher scores indicating a stronger therapeutic alliance.